ZNF423 modulates the AMP-activated protein kinase pathway and metformin response in a single nucleotide polymorphisms, estrogen and selective estrogen receptor modulator dependent fashion

Supplemental Digital Content is available in the text. Objectives We previously discovered that the single nucleotide polymorphisms (SNP) rs9940645 in the ZNF423 gene regulate ZNF423 expression and serve as a potential biomarker for response to selective estrogen receptor modulators (SERMs). Here we explored pathways involved in ZNF423-mediated SERMs response and drugs that potentially sensitize SERMs. Methods RNA sequencing and label-free quantitative proteomics were performed to identify genes and pathways that are regulated by ZNF423 and the ZNF423 SNP. Both cultured cells and mouse xenograft models with different ZNF423 SNP genotypes were used to study the cellular responses to metformin. Results We identified ribosome and AMP-activated protein kinase (AMPK) signaling as potential pathways regulated by ZNF423 or ZNF423 rs9940645 SNP. Moreover, using clustered regularly interspaced short palindromic repeats/Cas9-engineered ZR75-1 breast cancer cells with different ZNF423 SNP genotypes, striking differences in cellular responses to metformin, either alone or in the combination of tamoxifen, were observed in both cell culture and the mouse xenograft model. Conclusions We found that AMPK signaling is modulated by the ZNF423 rs9940645 SNP in estrogen and SERM-dependent fashion. The ZNF423 rs9940645 SNP affects metformin response in breast cancer and could be a potential biomarker for tailoring the metformin treatment.

[1]  D. Cescon,et al.  A phase II randomized clinical trial of the effect of metformin versus placebo on progression-free survival in women with metastatic breast cancer receiving standard chemotherapy. , 2019, Breast.

[2]  H. Nawa,et al.  AMPK activation, eEF2 inactivation, and reduced protein synthesis in the cerebral cortex of hibernating chipmunks , 2019, Scientific Reports.

[3]  R. Weinshilboum,et al.  4-Hydroxytamoxifen enhances sensitivity of estrogen receptor α-positive breast cancer to docetaxel in an estrogen and ZNF423 SNP-dependent fashion , 2019, Breast Cancer Research and Treatment.

[4]  R. Hawkes,et al.  Zfp423/ZNF423 regulates cell cycle progression, the mode of cell division and the DNA-damage response in Purkinje neuron progenitors , 2017, Development.

[5]  B. Viollet,et al.  AMPK is not required for the effect of metformin on the inhibition of BMP6-induced hepcidin gene expression in hepatocytes , 2017, Scientific Reports.

[6]  R. Weinshilboum,et al.  Calmodulin-like protein 3 is an estrogen receptor alpha coregulator for gene expression and drug response in a SNP, estrogen, and SERM-dependent fashion , 2017, Breast Cancer Research.

[7]  Haiyan Hu,et al.  Integrative analyses shed new light on human ribosomal protein gene regulation , 2016, Scientific Reports.

[8]  Andrew D. Rouillard,et al.  Enrichr: a comprehensive gene set enrichment analysis web server 2016 update , 2016, Nucleic Acids Res..

[9]  L. Berstein,et al.  The phenomenon of acquired resistance to metformin in breast cancer cells: The interaction of growth pathways and estrogen receptor signaling , 2016, IUBMB life.

[10]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[11]  Bingshu E. Chen,et al.  Effect of metformin vs placebo on and metabolic factors in NCIC CTG MA.32. , 2015, Journal of the National Cancer Institute.

[12]  M. Horstmann,et al.  ZNF423: Transcriptional modulation in development and cancer , 2014, Molecular & cellular oncology.

[13]  R. Kalluri,et al.  PGC-1α mediates mitochondrial biogenesis and oxidative phosphorylation to promote metastasis , 2014, Nature Cell Biology.

[14]  R. Baron,et al.  Direct Transcriptional Repression of Zfp423 by Zfp521 Mediates a Bone Morphogenic Protein-Dependent Osteoblast versus Adipocyte Lineage Commitment Switch , 2014, Molecular and Cellular Biology.

[15]  Ji Ma,et al.  Metformin enhances tamoxifen-mediated tumor growth inhibition in ER-positive breast carcinoma , 2014, BMC Cancer.

[16]  V. G. Panse,et al.  A new system for naming ribosomal proteins. , 2014, Current opinion in structural biology.

[17]  Erin E. Carlson,et al.  Selective estrogen receptor modulators and pharmacogenomic variation in ZNF423 regulation of BRCA1 expression: individualized breast cancer prevention. , 2013, Cancer discovery.

[18]  R. Andersson,et al.  Metformin-mediated growth inhibition involves suppression of the IGF-I receptor signalling pathway in human pancreatic cancer cells , 2013, BMC Cancer.

[19]  Edward Y. Chen,et al.  Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool , 2013, BMC Bioinformatics.

[20]  B. Viollet,et al.  Biguanides suppress hepatic glucagon signaling by decreasing production of cyclic AMP , 2016 .

[21]  M. Pollak.  The insulin and insulin-like growth factor receptor family in neoplasia: an update , 2012, Nature Reviews Cancer.

[22]  Jeffrey A. Johnson,et al.  Mortality After Incident Cancer in People With and Without Type 2 Diabetes , 2012, Diabetes Care.

[23]  Ji-ping Wang,et al.  Isolated and combined action of tamoxifen and metformin in wild-type, tamoxifen-resistant, and estrogen-deprived MCF-7 cells , 2011, Breast Cancer Research and Treatment.

[24]  G. Z. Rocha,et al.  Metformin Amplifies Chemotherapy-Induced AMPK Activation and Antitumoral Growth , 2011, Clinical Cancer Research.

[25]  Kevin Struhl,et al.  Metformin decreases the dose of chemotherapy for prolonging tumor remission in mouse xenografts involving multiple cancer cell types. , 2011, Cancer research.

[26]  Edward Giovannucci,et al.  Diabetes and Cancer , 2010, Diabetes Care.

[27]  Soonmyung Paik,et al.  Use of archived specimens in evaluation of prognostic and predictive biomarkers. , 2009, Journal of the National Cancer Institute.

[28]  I. Grummt,et al.  AMP-activated protein kinase adapts rRNA synthesis to cellular energy supply , 2009, Proceedings of the National Academy of Sciences.

[29]  M. Beckmann,et al.  Association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifen. , 2009, JAMA.

[30]  Kevin Struhl,et al.  Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission. , 2009, Cancer research.

[31]  Funda Meric-Bernstam,et al.  Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  A. López-Rivas,et al.  TAK1 activates AMPK‐dependent cytoprotective autophagy in TRAIL‐treated epithelial cells , 2009, The EMBO journal.

[33]  N. Ruderman,et al.  SIRT1 Modulation of the Acetylation Status, Cytosolic Localization, and Activity of LKB1 , 2008, Journal of Biological Chemistry.

[34]  M Schwab,et al.  N‐myc enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesis , 2001, The EMBO journal.

[35]  D. Hardie,et al.  5-aminoimidazole-4-carboxamide riboside mimics the effects of insulin on the expression of the 2 key gluconeogenic genes PEPCK and glucose-6-phosphatase. , 2000, Diabetes.

[36]  R. Perry,et al.  Delta, a transcription factor that binds to downstream elements in several polymerase II promoters, is a functionally versatile zinc finger protein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[37]  R. Perry,et al.  Characterization of the multigene family encoding the mouse S16 ribosomal protein: strategy for distinguishing an expressed gene from its processed pseudogene counterparts by an analysis of total genomic DNA , 1985, Molecular and cellular biology.

[38]  O. Warburg.  [Origin of cancer cells]. , 1956, Oncologia.